Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).

Grainne M. O'Kane; Aruz M. Mesci; Eric Xueyu Chen; Cynthia M. Bocaya; Raymond Woo-Jun Jang; Ben X. Wang; Rebecca M. Prince; Giselle M. Boukhaled; Aisling S. Barry; Mark Doherty; David K. Wong; Lisa Wang; Anna Dodd; Laura A. Dawson; Jennifer J. Knox

doi:10.1200/JCO.2025.43.4_suppl.602

Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).

Grainne M. O'Kane
, Aruz M. Mesci
, Eric Xueyu Chen
, Cynthia M. Bocaya
, Raymond Woo-Jun Jang
, Ben X. Wang
, Rebecca M. Prince
, Giselle M. Boukhaled
, Aisling S. Barry
, Mark Doherty
, David K. Wong
, Lisa Wang
, Anna Dodd
, Laura A. Dawson
, Jennifer J. Knox

School of Medicine

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	602-602
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	43
Issue number	4_SUPPL
DOIs	https://doi.org/10.1200/JCO.2025.43.4_suppl.602
Publication status	Published - Feb 2025

Access to Document

10.1200/JCO.2025.43.4_suppl.602

Cite this

O'Kane, G. M., Mesci, A. M., Chen, E. X., Bocaya, C. M., Jang, R. W.-J., Wang, B. X., Prince, R. M., Boukhaled, G. M., Barry, A. S., Doherty, M., Wong, D. K., Wang, L., Dodd, A., Dawson, L. A., & Knox, J. J. (2025). Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD). Journal of Clinical Oncology, 43(4_SUPPL), 602-602. https://doi.org/10.1200/JCO.2025.43.4_suppl.602

@article{ce9343bc1f6b4271af57b4cf48920c08,

title = "Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).",

author = "O'Kane, \{Grainne M.\} and Mesci, \{Aruz M.\} and Chen, \{Eric Xueyu\} and Bocaya, \{Cynthia M.\} and Jang, \{Raymond Woo-Jun\} and Wang, \{Ben X.\} and Prince, \{Rebecca M.\} and Boukhaled, \{Giselle M.\} and Barry, \{Aisling S.\} and Mark Doherty and Wong, \{David K.\} and Lisa Wang and Anna Dodd and Dawson, \{Laura A.\} and Knox, \{Jennifer J.\}",

year = "2025",

month = feb,

doi = "10.1200/JCO.2025.43.4\_suppl.602",

language = "English",

volume = "43",

pages = "602--602",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "4\_SUPPL",

}

O'Kane, GM, Mesci, AM, Chen, EX, Bocaya, CM, Jang, RW-J, Wang, BX, Prince, RM, Boukhaled, GM, Barry, AS, Doherty, M, Wong, DK, Wang, L, Dodd, A, Dawson, LA & Knox, JJ 2025, 'Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).', Journal of Clinical Oncology, vol. 43, no. 4_SUPPL, pp. 602-602. https://doi.org/10.1200/JCO.2025.43.4_suppl.602

TY - JOUR

T1 - Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC

T2 - A phase II study (PEMRAD).

AU - O'Kane, Grainne M.

AU - Mesci, Aruz M.

AU - Chen, Eric Xueyu

AU - Bocaya, Cynthia M.

AU - Jang, Raymond Woo-Jun

AU - Wang, Ben X.

AU - Prince, Rebecca M.

AU - Boukhaled, Giselle M.

AU - Barry, Aisling S.

AU - Doherty, Mark

AU - Wong, David K.

AU - Wang, Lisa

AU - Dodd, Anna

AU - Dawson, Laura A.

AU - Knox, Jennifer J.

PY - 2025/2

Y1 - 2025/2

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pureucc&SrcAuth=WosAPI&KeyUT=WOS:001423524800015&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1200/JCO.2025.43.4_suppl.602

DO - 10.1200/JCO.2025.43.4_suppl.602

M3 - Meeting abstract

SN - 0732-183X

VL - 43

SP - 602

EP - 602

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 4_SUPPL

ER -

Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).

Access to Document

Other files and links

Cite this